Evidence map›Paper›PMID 36824691›Full record

ArticlePulmonary circulation2023

Aggrecan accumulates at sites of increased pulmonary arterial pressure in idiopathic pulmonary arterial hypertension.

Oscar van der Have, Timothy J Mead, Christian Westöö, Niccolò Peruzzi, Ayse C Mutgan, Christian Norvik, Martin Bech, André Struglics, Konrad Hoetzenecker, Hans Brunnström and 4 more

Open access · goldAbstract read
In one paragraph

Article in Pulmonary circulation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 4 countries.

Oscar van der HaveDepartment of Experimental Medical Science, Faculty of Medicine Lund University Lund Sweden.ORCID 0000-0003-4726-0697
Timothy J MeadDepartment of Biomedical Engineering Cleveland Clinic Lerner Research Institute Cleveland Ohio USA.ORCID 0000-0003-1891-3652
Christian WestööDepartment of Experimental Medical Science, Faculty of Medicine Lund University Lund Sweden.
Niccolò PeruzziDepartment of Experimental Medical Science, Faculty of Medicine Lund University Lund Sweden.
Ayse C MutganLudwig Boltzmann Institute for Lung Vascular Research Graz Austria.
Christian NorvikDepartment of Experimental Medical Science, Faculty of Medicine Lund University Lund Sweden.
Martin BechDepartment of Medical Radiation Physics, Clinical Sciences Lund Lund University Lund Sweden.
André StruglicsDepartment of Clinical Sciences Lund, Orthopaedics, Faculty of Medicine Lund University Lund Sweden.
Konrad HoetzeneckerDepartment of Thoracic Surgery Medical University of Vienna Vienna Austria.
Hans BrunnströmDepartment of Clinical Sciences Lund, Division of Pathology, Faculty of Medicine Lund University Lund Sweden.
Gunilla Westergren-ThorssonDepartment of Experimental Medical Science, Faculty of Medicine Lund University Lund Sweden.
Grazyna KwapiszewskaLudwig Boltzmann Institute for Lung Vascular Research Graz Austria.
Suneel S ApteDepartment of Biomedical Engineering Cleveland Clinic Lerner Research Institute Cleveland Ohio USA.
Karin Tran-LundmarkDepartment of Experimental Medical Science, Faculty of Medicine Lund University Lund Sweden.
Lund University · SECleveland Clinic Lerner College of Medicine · USJustus-Liebig-Universität Gießen · DEMedical University of Graz · ATMedical University of Vienna · AT

Funding

Proteoglycan dynamics in pathogenesis of thoracic aortic aneurysm and dissectionR56HL141130 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI APTE, SUNEEL S · 2018 to 2018
$400k
NHLBI NIH HHS R56 HL141130
6 · The paper itself

Abstract

Expansion of extracellular matrix occurs in all stages of pulmonary angiopathy associated with pulmonary arterial hypertension (PAH). In systemic arteries, dysregulation and accumulation of the large chondroitin-sulfate proteoglycan aggrecan is associated with swelling and disruption of vessel wall homeostasis. Whether aggrecan is present in pulmonary arteries, and its potential roles in PAH, has not been thoroughly investigated. Here, lung tissue from 11 patients with idiopathic PAH was imaged using synchrotron radiation phase-contrast microcomputed tomography (TOMCAT beamline, Swiss Light Source). Immunohistochemistry for aggrecan core protein in subsequently sectioned lung tissue demonstrated accumulation in PAH compared with failed donor lung controls. RNAscope in situ hybridization indicated

Indexed as

extracellular matrixproteoglycanpulmonary arterial hypertensionsynchrotron imagingvascular disease

Identifiers

PMID36824691
PMCPMC9941846
OpenAlexW4319787693

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.